Clinical trial
A Multi-center, Randomized, Double Blind, Placebo Controlled Study to Investigate the Efficacy and Safety of Aprotinin on Transfusion Requirements in Patients With Bladder Cancer Undergoing Radical or Total Cystectomy.
NCT00306150 is registered in ClinicalTrials.gov with Bayer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-center, Randomized, Double Blind, Placebo Controlled Study to Investigate the Efficacy and Safety of Aprotinin on Transfusion Requirements in Patients With Bladder Cancer Undergoing Radical or Total Cystectomy.
- Lead sponsor
- Bayer
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- December 31, 2005
- Completion date
- March 31, 2007
- Enrollment
- 57 (actual)
- Sites
- 37
Conditions
As the registry lists them; a condition with its own page is linked.